Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

FIRST ON FOX A nonprofit group dedicated to patient rights is urging President Donald Trump to take decisive action to improve price transparency in healthcare. This plea comes as the White House prepares to introduce a new healthcare initiative.
The Patients Rights Advocate, a nonpartisan organization focused on improving healthcare price transparency and quality, has called on the Trump administration to enhance patients’ understanding of healthcare costs. As the White House gears up to reveal its new healthcare proposal, the timing of their request is crucial.
In a letter directed at Trump, PRA founder Cynthia Fisher emphasized the need for patients—not insurance companies—to regain control of their healthcare spending. She stated, “You recently articulated a compelling vision: Americans should manage their healthcare dollars, not the insurance companies. Empowering individuals is vital for restoring fairness, choice, and accountability in a system that has long favored corporate interests over the American public.”
Fisher explicitly suggested that Trump enlist the Department of Labor to mandate that employers with health plans have complete access to claims data, payments to providers, and an overview of associated fees. This transparency could foster negotiation between employers and healthcare providers, ultimately leading to reduced costs for employees.
Moreover, Fisher advocated for Trump to support the Patients Deserve Price Tags Act, championed by Republican Senator Roger Marshall of Kansas and Democratic Senator John Hickenlooper of Colorado. This legislation would obligate hospitals to disclose the actual prices for roughly 300 services and require itemized billing for every component of patient care.
Fisher boldly asserted, “By implementing these measures, you can create a framework where patients, employers, and unions—not the profit-driven interests of insurance companies and private equity firms—call the shots on healthcare expenses.”
These proposed actions would build on earlier initiatives from the Trump administration. In February, Trump signed an executive order mandating that the Treasury, Labor, and Health and Human Services Departments enforce transparency regulations. This order aims to require hospitals and insurers to disclose actual healthcare prices rather than mere estimates. The goal is to make pricing more consistent across facilities and insurers.
The precise timing for the release of Trump’s healthcare proposal remains uncertain. Recent media reports have speculated that the plan could be unveiled as soon as Monday. However, White House Press Secretary Karoline Leavitt did not offer a definitive timeline, stating that the issue is a priority for the administration.
The anticipated healthcare plan surfaces amid ongoing discussions among Republicans about whether to extend the Affordable Care Act subsidies, which are set to expire at the end of 2025. These discussions became a significant hurdle in negotiations that resulted in the recent government shutdown.
Despite long-standing resistance from Democrats, who sought a permanent extension of Affordable Care Act subsidies, a short-term spending bill has now passed without this provision. Meanwhile, Senate Majority Leader John Thune from South Dakota has indicated willingness to hold a vote in December about extending these crucial credits.
Simultaneously, public sentiment shows a clear demand for healthcare pricing transparency. A September poll conducted by Echelon Insights revealed that around 90% of U.S. voters favor regulations compelling hospitals and insurance companies to disclose precise costs right from the start.
David Kochel, a Republican campaign strategist, expressed confidence in the overwhelming support for the proposed actions. He stated, “The data I’ve seen is crystal clear: If President Trump follows through on enforcing price transparency, the American public will largely favor it. This isn’t just sound policy; it’s a potential game-changer as we head into 2026 and beyond. By addressing the prevalent issues of surprise medical bills and obfuscated pricing, Republicans have a chance to reshape the healthcare narrative, regain public trust, and provide tangible benefits to voters.”
The push for healthcare price transparency highlights a critical moment in the ongoing debate over healthcare reform in America. Advocacy groups, like the Patients Rights Advocate, are stepping up to demand that policymakers prioritize the interests of patients over corporate profits. The outcome of these discussions might not only reshape the healthcare landscape but also influence voters’ perceptions leading into the next electoral cycle. As the conversation continues to evolve, the emphasis on patient empowerment remains a fundamental priority for advocates across the nation.